SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001626199-22-000006
Filing Date
2022-01-04
Accepted
2022-01-04 17:19:51
Documents
1
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164133476170143.html 4  
1 FORM 4 wf-form4_164133476170143.xml 4 4643
  Complete submission text file 0001626199-22-000006.txt   6336
Mailing Address C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address
Thompson Peter A. (Reporting) CIK: 0001357522 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 22507493

Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations